Related Experiment Video
Updated: Apr 18, 2026

06:37
Multispectral Real-time Fluorescence Imaging for Intraoperative Detection of the Sentinel Lymph Node in Gynecologic Oncology
Published on: October 20, 2010
24.0K
Multi-channel LED light source for fluorescent agent aided minimally invasive surgery.
Summary
This study developed a low-cost LED endoscope light source to improve cancer surgery. It enhances tumor margin visualization using indocyanine green (ICG) and 5-Aminolaevulinic acid (ALA)-induced protoporphyrin IX (PPIX) for better surgical outcomes.
Area of Science:
- Medical Devices
- Surgical Oncology
- Biophotonics
Background:
- Cancer surgery requires precise tumor margin detection for effective treatment.
- Current endoscopic illumination lacks specificity for visualizing tumor boundaries.
- Contrast agents like ICG and ALA-PPIX show promise but require specific light excitation.
Purpose of the Study:
- To develop a novel, cost-effective LED endoscope light source for enhanced tumor margin visualization.
- To enable dual-channel excitation for common fluorescence-guided surgery agents.
- To support minimally invasive cancer surgeries with improved intraoperative guidance.
Main Methods:
- Designed and constructed a portable LED light source with white light and two specific excitation channels.
- Integrated capabilities to excite indocyanine green (ICG) and 5-Aminolaevulinic acid (ALA)-induced protoporphyrin IX (PPIX).
- Evaluated the light source's performance for visualizing tumor margins in a surgical context.
Main Results:
- The developed LED light source successfully provides white light and two distinct excitation channels.
- It enables visible imaging of tumor margins by exciting ICG and ALA-PPIX.
- The prototype is portable, user-friendly, and built at a low cost (under $300).
Conclusions:
- The novel LED endoscope light source offers a practical solution for improving tumor margin detection during surgery.
- This technology has the potential to enhance surgical precision and patient outcomes in cancer treatment.
- The low cost and portability make it an accessible tool for wider clinical adoption.

